APA (7th ed.) Citation

A, Y., S, H., A, A., R, G., VE, M., MJ, F., . . . F, B. (2025). COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection. Neurology(R) neuroimmunology & neuroinflammation, 12(5), e200443. https://doi.org/10.1212/NXI.0000000000200443

Chicago Style (17th ed.) Citation

A, Yeola, et al. "COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection." Neurology(R) Neuroimmunology & Neuroinflammation 12, no. 5 (2025): e200443. https://doi.org/10.1212/NXI.0000000000200443.

MLA (9th ed.) Citation

A, Yeola, et al. "COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection." Neurology(R) Neuroimmunology & Neuroinflammation, vol. 12, no. 5, 2025, p. e200443, https://doi.org/10.1212/NXI.0000000000200443.